David Brennan, CEO of Astra Zeneca, will take part in the plenary session panel discussion on “Ethical Practices in the Pharmaceutical Sector” at the EuroMeeting 2012 in Copenhagen on Monday 26 March. Mr Brennan will join fellow panel members representing the pharma industry, patient groups, patients, regulatory authorities and academia. The discussion forms part of the afternoon plenary session, which runs from 1400 – 1730, and will be opened by Morten Østergaard, Danish Minister of Science, Innovation and Higher Education.
Nicola Bedlington, Director European Patients Forum
Hazel Biggs, Professor of Health Care Law and Bioethics, University of Southampton
David Brennan, CEO AstraZeneca
Nikos Dedes, HIV-patient
Liselotte Højgaard, Professor Rigshospitalet, Copenhagen
Guido Rasi, Executive Director, European Medicines Agency
Lars Rebien Sørensen, CEO Novo Nordisk
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.
Contact: Robin Gallon
Phone: +41 61 225 51 47